Singular Genomics Systems, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Singular Genomics Systems, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Singular Genomics Systems, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$16.8M, a 24.9% increase year-over-year.
  • Singular Genomics Systems, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$86.3M, a 6.85% increase year-over-year.
  • Singular Genomics Systems, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$94.8M, a 4.34% decline from 2022.
  • Singular Genomics Systems, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$90.9M, a 7.99% increase from 2021.
  • Singular Genomics Systems, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$98.8M, a 253% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$86.3M -$16.8M +$5.57M +24.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$91.9M -$21.3M +$4.32M +16.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-12
Q1 2024 -$96.2M -$25M -$1.39M -5.89% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-12
Q4 2023 -$94.8M -$23.2M -$2.15M -10.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 -$92.7M -$22.4M +$1.43M +6.01% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$94.1M -$25.6M -$1.6M -6.66% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-12
Q1 2023 -$92.5M -$23.6M -$1.63M -7.39% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-12
Q4 2022 -$90.9M -$21.1M -$1.34M -6.79% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 -$89.5M -$23.8M -$6.18M -35.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$83.4M -$24M +$13.5M +36% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-14
Q1 2022 -$96.9M -$22M +$1.92M +8.01% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-14
Q4 2021 -$98.8M -$19.8M -$13.4M -213% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$85.3M -$17.6M -$9.68M -122% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$75.7M -$37.5M -$30.6M -447% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$45M -$23.9M -$17.1M -249% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-07
Q4 2020 -$27.9M -$6.32M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$7.93M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$6.85M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$6.85M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.